Illumina Inc.

Research conducted at D.W. Craig and co-authors has provided new information about end stage renal disease.
Diabetes Week; 12/21/2009; 816 words; ...Caucasian individuals with Type 1 diabetes." "We utilized the Illumina Infinium II HumanHap 550 beadchip platform to genotype 555 352...journal Diabetic Medicine is: Wiley-Blackwell Publishing, Inc., Commerce Place, 350 Main St., Malden 02148, MA, USA...

ILLUMINA REPORTS MULTIPLE TRANSACTIONS BY CEO FLATLEY (California)
US Fed News Service, Including US State News; 12/19/2009; 309 words; WASHINGTON, Dec. 19 -- Illumina Inc. (ILMN), San Diego, has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial interest...

Deep Sequencing for 'Profound Insight' into Tumors, DNA Repair.
BIOWORLD Today; 12/17/2009; 1271 words; ...individual cancer," he said. In two separate papers, Stratton and his colleagues, including industrial co-authors from Illumina Inc. and Life Technologies, respectively, sequenced one example of a melanoma and one of a lung tumor. The two cancers...

Biotech Gets Back on Track in November.
Biotech Week; 12/16/2009; 836 words; ...respectively. On the negative side of the list were Illumina (-10 percent) and Affymetrix (-10 percent...public offering. Keywords: Amylin Pharmaceuticals Inc., Biogen Idec Inc., Biotechnology Business, Biotechnology Company...

TRADE NEWS: Agilent Technologies Appoints Fasteris First European Certified-Service Provider for Agilent's Next-Generation Sequencing Target Enrichment System.
Journal of Technology; 12/15/2009; 943 words; Agilent Technologies Inc. (NYSE:A) and Fasteris...SureSelect system with the Illumina Genome Analyzer. "Fasteris...company to acquire an Illumina Genome Analyzer system...incorporated into the Illumina Genome Analyzer System...Agilent Technologies Inc. (NYSE: A) is the...